EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions

Afolarin A Otunla, Kumaran Shanmugarajah, Alun H Davies, Joseph Shalhoub

Frontiers in Pharmacology · 23.02.2024 · 15

DOI: 10.3389/fphar.2024.1355674 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.02.2024. Verfasst von Afolarin A Otunla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Biotechnology, University College London, London, United Kingdom. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated lipid metabolism is implicated in the pathophysiology of a range of kidney diseases. The specific mechanisms through which lipotoxicity contributes to acute kidney injury (AKI) remain poorly understood. Herein we review the cardinal features of lipotoxic injury in ischemic kidney injury; lipid accumulation and mitochondrial lipotoxicity. We then explore a new mechanism of lipotoxicity, what we define as “immunometabolic” lipotoxicity, and discuss the potential therapeutic implications of targeting this lipotoxicity using lipid lowering medications.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injuryimmunometabolismischemialipotoxicitymitcohondria

Autor:innen und Institutionen

  • Department of Surgical Biotechnology, University College London, London, United Kingdom.
  • Cleveland Clinic, Cleveland Clinic Transplant Centre, Cleveland, OH, United States.
  • UK and Imperial Vascular Unit, Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Imperial College Healthcare NHS Trust, London, United Kingdom.

Zitieren

APA

Otunla, A. A., Shanmugarajah, K., Davies, A. H., & Shalhoub, J. (2024). Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1355674

Vancouver

Otunla AA, Shanmugarajah K, Davies AH, Shalhoub J. Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1355674

BibTeX
@article{Otunla2024,
  author = {Otunla, Afolarin A and Shanmugarajah, Kumaran and Davies, Alun H and Shalhoub, Joseph},
  title = {Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1355674}
}
Kostenlos starten →